香港种子医学推出肥胖症GLP-1体重计划,强调医疗监督和安全。 SeedMedical Hong Kong launches GLP-1 weight program for obesity, stressing medical oversight and safety.

香港种子医疗公司推出了一项医疗监督的体重管理计划,使用GLP-1技术帮助肥胖或超重的个体,特别是那些BMI为30或以上或2729.9且有相关健康问题的人. SeedMedical Hong Kong has launched a medically supervised weight management program using GLP-1 technology to help individuals with obesity or overweight conditions, particularly those with a BMI of 30 or higher, or 27–29.9 with related health issues. 该方案包括综合健康评估和个性化计划,利用GLP-1的能力减少食欲和食物摄入。 The program includes comprehensive health assessments and personalized plans, leveraging GLP-1’s ability to reduce appetite and food intake. 它强调医疗监督、适当的剂量和持续监测,以确保安全和长期成功。 It emphasizes medical oversight, proper dosing, and ongoing monitoring to ensure safety and long-term success. 由于伪造和不当储存等风险,该公司对无管制产品提出警告,强调只有持有许可证的供应商才能确保质量和合规。 The company warns against unregulated products due to risks like counterfeiting and improper storage, stressing that only licensed providers can ensure quality and compliance. 这项服务是香港更广泛的健康管理服务的一部分。 The service is part of broader health management offerings in Hong Kong.